Terms: = Breast cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Diagnosis
66 results:
1. Study on the differential diagnosis of benign and malignant breast lesions using a deep learning model based on multimodal images.
Du Y; Wang D; Liu M; Zhang X; Ren W; Sun J; Yin C; Yang S; Zhang L
J Cancer Res Ther; 2024 Apr; 20(2):625-632. PubMed ID: 38687933
[TBL] [Abstract] [Full Text] [Related]
2. Plasma microRNA-195, -34c, and - 1246 as novel biomarkers for the diagnosis of trastuzumab-resistant HER2-positive breast cancer patients.
Rezaei Z; Dastjerdi K; Allahyari A; ShahidSales S; Talebian S; Maharati A; Zangooie A; Zangouei AS; Sadri F; Sargazi S
Toxicol Appl Pharmacol; 2023 Sep; 475():116652. PubMed ID: 37557922
[TBL] [Abstract] [Full Text] [Related]
3. Mammographic density and interval cancers in mammographic screening: Moving towards more personalized screening.
Larsen M; Lynge E; Lee CI; Lång K; Hofvind S
Breast; 2023 Jun; 69():306-311. PubMed ID: 36966656
[TBL] [Abstract] [Full Text] [Related]
4. Disparities in the use of assisted reproductive technologies after breast cancer: a population-based study.
Meernik C; Jorgensen K; Wu CF; Murphy CC; Baker VL; Brady PC; Nitecki R; Nichols HB; Rauh-Hain JA
Breast Cancer Res Treat; 2023 Feb; 198(1):149-158. PubMed ID: 36607486
[TBL] [Abstract] [Full Text] [Related]
5. Cell cycle related long non-coding RNAs as the critical regulators of breast cancer progression and metastasis.
Zangouei AS; Zangoue M; Taghehchian N; Zangooie A; Rahimi HR; Saburi E; Alavi MS; Moghbeli M
Biol Res; 2023 Jan; 56(1):1. PubMed ID: 36597150
[TBL] [Abstract] [Full Text] [Related]
6. Genomic Landscape of Circulating-Tumor DNA in a Diverse Cohort of Metastatic breast cancer Patients.
Cheng S; Nguyen ET; Pagano I; Fukui JA
Oncol Res Treat; 2023; 46(1-2):26-32. PubMed ID: 36481616
[TBL] [Abstract] [Full Text] [Related]
7. Health-related quality of life among breast cancer patients in India.
Gupta N; Pandey AK; Dimri K; Jyani G; Goyal A; Prinja S
Support Care Cancer; 2022 Dec; 30(12):9983-9990. PubMed ID: 36222977
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathological features of male patients with breast cancer based on a nationwide registry database in Japan.
Shimomura A; Nagahashi M; Kumamaru H; Aogi K; Asaga S; Hayashi N; Iijima K; Kadoya T; Kojima Y; Kubo M; Miyashita M; Miyata H; Niikura N; Ogo E; Tamura K; Tanakura K; Yoshida M; Yamamoto Y; Imoto S; Jinno H
Breast Cancer; 2022 Nov; 29(6):985-992. PubMed ID: 35733033
[TBL] [Abstract] [Full Text] [Related]
9. Rapid and efficient capturing of circulating tumor cells from breast cancer Patient's whole blood via the antibody functionalized microfluidic (AFM) chip.
Abdulla A; Zhang Z; Ahmad KZ; Warden AR; Li H; Ding X
Biosens Bioelectron; 2022 Apr; 201():113965. PubMed ID: 35016111
[TBL] [Abstract] [Full Text] [Related]
10. Statin use and patterns of breast cancer recurrence in the Malmö Diet and cancer Study.
Inasu M; Feldt M; Jernström H; Borgquist S; Harborg S
Breast; 2022 Feb; 61():123-128. PubMed ID: 34995921
[TBL] [Abstract] [Full Text] [Related]
11. Determinants of late detection and advanced-stage diagnosis of breast cancer in Nigeria.
Agodirin O; Olatoke S; Rahman G; Kolawole O; Oguntola S; Olasehinde O; Ayandipo O; Olaogun J; Katung A; Etonyeaku A; Habeeb O; Adeyeye A; Agboola J; Akande H; Akanbi O; Fatudimu O; Ajiboye A
PLoS One; 2021; 16(11):e0256847. PubMed ID: 34731161
[TBL] [Abstract] [Full Text] [Related]
12. Nuclear grade and comedo necrosis of ductal carcinoma in situ as histopathological eligible criteria for the Japan Clinical Oncology Group 1505 trial: an interobserver agreement study.
Tsuda H; Yoshida M; Akiyama F; Ohi Y; Kinowaki K; Kumaki N; Kondo Y; Saito A; Sasaki E; Nishimura R; Fujii S; Homma K; Horii R; Murata Y; Itami M; Kajita S; Kato H; Kurosumi M; Sakatani T; Shimizu S; Taniguchi K; Tamiya S; Nakamura H; Kanbayashi C; Shien T; Iwata H
Jpn J Clin Oncol; 2021 Mar; 51(3):434-443. PubMed ID: 33420502
[TBL] [Abstract] [Full Text] [Related]
13. Introduction of hsa-miR-512-3p as a new regulator of HER2 signaling pathway in breast cancer.
Mohamadzade Z; Mahjoubi F; Soltani BM
Breast Cancer Res Treat; 2021 Jan; 185(1):95-106. PubMed ID: 32974790
[TBL] [Abstract] [Full Text] [Related]
14. Distance between tumor and nipple as a prognostic factor in breast cancers: Opposite effects in young and old patients.
Yang Q; Yang J; Xu L; Zhou C; Lv Q
Medicine (Baltimore); 2020 Aug; 99(32):e21461. PubMed ID: 32769875
[TBL] [Abstract] [Full Text] [Related]
15. Cyclin D1 overexpression in Algerian breast cancer women: correlation with ccnd1 amplification and clinicopathological parameters.
Mohammedi L; Doula FD; Mesli F; Senhadji R
Afr Health Sci; 2019 Jun; 19(2):2140-2146. PubMed ID: 31656498
[TBL] [Abstract] [Full Text] [Related]
16. breast cancer in San Francisco: Disentangling Disparities at the Neighborhood Level.
Guan A; Lichtensztajn D; Oh D; Jain J; Tao L; Hiatt RA; Gomez SL; Fejerman L;
Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):1968-1976. PubMed ID: 31548180
[TBL] [Abstract] [Full Text] [Related]
17. Clinicopathological and Prognostic Role of STAT3/p-STAT3 in breast cancer Patients in China: A Meta-Analysis.
Li Y; Wang Y; Shi Z; Liu J; Zheng S; Yang J; Liu Y; Yang Y; Chang F; Yu W
Sci Rep; 2019 Aug; 9(1):11243. PubMed ID: 31375715
[TBL] [Abstract] [Full Text] [Related]
18. Self-reported residential pesticide use and survival after breast cancer.
Niehoff NM; Gammon MD; Parada H; Stellman SD; Neugut AI; Teitelbaum SL
Int J Hyg Environ Health; 2019 Sep; 222(8):1077-1083. PubMed ID: 31351853
[TBL] [Abstract] [Full Text] [Related]
19. Potentially inappropriate medications defined by STOPP criteria in older patients with breast and colorectal cancer.
Karuturi MS; Holmes HM; Lei X; Johnson M; Barcenas CH; Cantor SB; Gallick GE; Bast RC; Giordano SH
J Geriatr Oncol; 2019 Sep; 10(5):705-708. PubMed ID: 30795923
[TBL] [Abstract] [Full Text] [Related]
20. Artificial Light at Night of Different Spectral Compositions Differentially Affects Tumor Growth in Mice: Interaction With Melatonin and Epigenetic Pathways.
Zubidat AE; Fares B; Fares F; Haim A
Cancer Control; 2018; 25(1):1073274818812908. PubMed ID: 30477310
[TBL] [Abstract] [Full Text] [Related]
[Next]
